Husam Balkhy, M.D. to Present Clinical Study Results of Cardica’s C-Port® Distal Anastomosis System at the Annual Meeting ...
May 11 2016 - 1:00PM
Cardica, Inc. (Nasdaq:CRDC) today announced that the results of a
clinical study of the C-Port® Distal Anastomosis System will be
presented at the Annual Meeting of the American Association for
Thoracic Surgery (AATS) in Baltimore, Maryland by Husam Balkhy,
M.D., associate professor of Surgery and director of Robotic and
Minimally Invasive Cardiac Surgery at The University of Chicago’s
Medicine & Biological Sciences Division. Dr. Balkhy’s
presentation is scheduled to take place on May 17, 2016 at 7
a.m. ET.
The MAGIC (Multicenter Assessment of Grafts in Coronaries)
Study, a long-term post-market evaluation of the C-Port device,
examined acute-to-mid-term and long-term vein graft occlusion rates
for coronary revascularization using the C-Port compared to
hand-sewn anastomoses. Patients receiving at least one C-Port
anastomosis during coronary artery bypass grafting (CABG) surgery
were enrolled at eight sites in the United States.
About the C-Port® Distal Anastomosis Systems (C-Port
systems)The C-Port systems – the C-Port xA system and the
Flex-A® system – can be used on- or off-pump and create compliant
anastomoses that expand and contract with blood flow. With
miniature stainless steel staples to secure the bypass graft to the
coronary artery, C-Port reduces time required for anastomosis. The
C-Port systems work on coronary arteries as small as 1.25
millimeters in internal diameter and work with grafts of various
diameters and wall thicknesses less than 1.4 millimeters. The
Flex-A system allows surgeons to position the device to create a
secure connection even in the most difficult to reach areas of the
heart.
About CardicaCardica designs and manufactures
proprietary stapling and automated anastomotic devices for cardiac
and laparoscopic surgical procedures. Cardica's technology
portfolio is intended to minimize operating time and enable
minimally-invasive and robot-assisted surgeries. Cardica
manufactures and markets its automated anastomosis systems, the
C-Port® Distal Anastomosis Systems and PAS-Port® Proximal
Anastomosis System for coronary artery bypass graft (CABG) surgery,
and has shipped over 56,500 units throughout the world. In
addition, Cardica’s MicroCutter XCHANGE® 30, the world’s
smallest-profile articulating stapler, is manufactured and cleared
for use in the U.S. for transection and resection in multiple open
or minimally invasive urologic, thoracic and pediatric surgical
procedures, as well as application for transection, resection
and/or creation of anastomoses in the small and large intestine and
the transection of the appendix.
Contact:
Investors:
Bob Newell
Vice President, Finance and Chief Financial Officer
(650) 331-7133
investors@cardica.com
Media:
Jessica Volchok
(310) 849-7985
jessica@nicoleosmer.com